Protected: Novel triplet therapy for newly diagnosed multiple myeloma patients now PBS listed

By ONA Editor June 1, 2020 No Comments

About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

This post is password protected. Enter the password to view comments.

Subscribe for News Updates
Search Oncology News
Search for:
Speak your mind!

Passionate about a development that deserves more attention? Views on a controversial issue?

Oncology News publishes commentary pieces from oncology professionals here and in The Oncology Newsletter.

Contact us to discuss
Subscribe for News Updates

The Oncology Newsletter is a free publication distributed to healthcare professionals every week, featuring news, views, reviews and the latest jobs. Subscribe.
About Us

Oncology News Australia is a small group of publishing, media and digital professionals providing resources for the oncology community. More information.
Advertising with Us

If you seek to connect and present your product or service to an engaged oncology healthcare community, you have come to the right place. More information.

Timing and intensity of oral sex may affect risk of oropharyngeal cancer

Study shows that mindfulness can help ease the pain of breast cancer survivors

Timing and intensity of oral sex may affect risk of oropharyngeal cancer

Study shows that mindfulness can help ease the pain of breast cancer survivors

Protected: Novel triplet therapy for newly diagnosed multiple myeloma patients now PBS listed

About Author

Timing and intensity of oral sex may affect risk of oropharyngeal cancer

Study shows that mindfulness can help ease the pain of breast cancer survivors

Timing and intensity of oral sex may affect risk of oropharyngeal cancer

Study shows that mindfulness can help ease the pain of breast cancer survivors

About Author

Related Posts

FDA approves carfilzomib and daratumumab with dexamethasone for multiple myeloma

Protected: Neoadjuvant treatment key to unlocking benefits of PBS-listed Kadcyla® (trastuzumab emtansine) in the adjuvant setting

Genetic test could pick out ‘ultra high risk’ bone marrow cancer patients